International Journal of Hypertension [14] G. Ligtenberg, P. J. Blankestijn, P. L. Oey et al., “Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure,” New England Journal of Medicine, vol. 340, no. 17, pp. 1321–1328, 1999. [15] R. L. Converse, T. N. Jacobsen, R. D. Toto et al., “Sympathetic overactivity in patients with chronic renal failure,” New England Journal of Medicine, vol. 327, no. 27 I, pp. 1912–1918, 1992. [16] S. Ye, B. Ozgur, and V. M. Campese, “Renal aﬀerent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure,” Kidney International, vol. 51, no. 3, pp. 722–727, 1997. [17] R. Bigazzi, E. Kogosov, and V. M. Campese, “Altered nore- pinephrine turnover in the brain of rats with chronic renal failure,” Journal of the American Society of Nephrology, vol. 4, no. 11, pp. 1901–1907, 1994. [18] F. R. Calaresu, P. Kim, H. Nakamura, and A. Sato, “Electro- physiological characteristics of renorenal reﬂexes in the cat,” Journal of Physiology, vol. 283, pp. 141–154, 1978. [19] J. Ciriello and F. R. Calaresu, “Central projections of aﬀerent renal ﬁbers in the rat: an anterograde transport study of horseradish peroxidase,” Journal of the Autonomic Nervous System, vol. 8, no. 3, pp. 273–285, 1983. [20] G. DiBona, “The function of the renal nerves,” Reviews of Physiology, Biochemistry & Pharmacology, vol. 94, pp. 75–181, 1982. [21] J. E. Faber and M. J. Brody, “Aﬀerent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat,” Circulation Research, vol. 57, no. 5, pp. 676– 688, 1985. [22] M. J. Brody, “Role of the anteroventral third ventricle region in ﬂuid and electrolyte balance, arterial pressure regulation and hypertension,” in Frontiers in Neuroendocrinology, W. F. Ganong, Ed., pp. 249–292, Raven Press, New York, NY, USA, 1980. [23] R. E. Katholi, P. L. Whitlow, G. R. Hageman, and W. T. Woods, “Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog,” Journal of Hypertension, vol. 2, no. 4, pp. 349–359, 1984. [24] J. M. Wyss, N. Aboukarsh, and S. Oparil, “Sensory denervation of the kidney attenuates renovascular hypertension in the rat,” American Journal of Physiology, vol. 250, no. 1, part 2, pp. H82– H86, 1986. [25] R. E. Katholi, S. R. Winternitz, and S. Oparil, “Decrease in peripheral sympathetic nervous system activity following renal denervation or unclipping in the one-kidney one-clip Goldblatt hypertensive rat,” Journal of Clinical Investigation, vol. 69, no. 1, pp. 55–62, 1982. [26] U. C. Kopp, L. A. Olson, and G. F. DiBona, “Renorenal reﬂex responses to mechano- and chemoreceptor stimulation in the dog and rat,” The American journal of physiology, vol. 246, no. 1, part 2, pp. F67–F77, 1984. [27] R. E. Katholi, “Renal nerves and hypertension: an update,” Federation Proceedings, vol. 44, no. 13, pp. 2846–2850, 1985. [28] V. M. Campese, E. Kogosov, and M. Koss, “Renal aﬀerent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat,” American Journal of Kidney Diseases, vol. 26, no. 5, pp. 861– 865, 1995. [29] S. Ye, M. Gamburd, P. Mozayeni, M. Koss, and V. M. Campese, “A limited renal injury may cause a permanent form of neurogenic hypertension,” American Journal of Hypertension, vol. 11, pp. 723–728, 1998. 5 [30] I. H. H. T. Klein, G. Ligtenberg, P. L. Oey, H. A. Koomans, and P. J. Blankestijn, “Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension,” Journal of the American Society of Nephrology, vol. 12, no. 11, pp. 2427–2433, 2001. [31] V. Campese, “Hypertension in dialysis patients,” in Principles and Practice of Dialysis, W. Henrich, Ed., pp. 209–234, Williams & Wilkins, Baltimore, Md, USA, 1999. [32] V. M. Campese, S. Ye, and H. Zhong, “Downregulation of neuronal nitric oxide synthase and interleukin-1β mediates angiotensin II-dependent stimulation of sympathetic nerve activity,” Hypertension, vol. 39, no. 2, part 2, pp. 519–524, 2002. [33] V. M. Campese, S. Ye, R. H. Truong, and M. Gamburd, “Losartan reduces sympathetic nerve outﬂow from the brain of rats with chronic renal failure,” Journal of the Renin- Angiotensin-Aldosterone System, vol. 1, no. 2, pp. 202–208, 2000. [34] S. Ye, H. Zhong, VU. N. Duong, and V. M. Campese, “Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension,” Hypertension, vol. 39, no. 6, pp. 1101–1106, 2002. [35] V. M. Campese, S. Ye, H. Zhong, V. Yanamadala, Z. Ye, and J. Chiu, “Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity,” American Journal of Physiology, vol. 287, no. 2, pp. H695–H703, 2004. [36] S. Ye, H. Zhong, and V. M. Campese, “Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension,” Hypertension, vol. 48, no. 2, pp. 309–315, 2006. [37] T. Kishi, Y. Hirooka, Y. Kimura, K. Ito, H. Shimokawa, and A. Takeshita, “Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats,” Circulation, vol. 109, no. 19, pp. 2357–2362, 2004. [38] E. B. Oliveira-Sales, E. E. Nishi, B. A. Carillo et al., “Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension,” Amer- ican Journal of Hypertension, vol. 22, no. 5, pp. 484–492, 2009. [39] V. M. Campese, YE. Shaohua, and Z. Huiquin, “Oxidative stress mediates angiotensin II-dependent stimulation of sym- pathetic nerve activity,” Hypertension, vol. 46, no. 3, pp. 533– 539, 2005. [40] M. C. Zimmerman, E. Lazartigues, J. A. Lang et al., “Super- oxide mediates the actions of angiotensin II in the central nervous system,” Circulation Research, vol. 91, no. 11, pp. 1038–1045, 2002. [41] AI. Nagae, M. Fujita, H. Kawarazaki, H. Matsui, K. Ando, and T. Fujita, “Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension,” Circulation, vol. 119, no. 7, pp. 978–986, 2009. [42] M. Fujjita, K. Ando, A. Nagae, and T. Fujita, “Sympathoexcita- tion by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension,” Hypertension, vol. 50, no. 2, pp. 354–359, 2007. [43] E. Miyajima, Y. Yamada, Y. Yoshida et al., “Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism,” Hypertension, vol. 17, no. 6, part 2, pp. 1057– 1062, 1991. [44] W. M. Bernhardt, M. S. Wiesener, A. Weidemann et al., “Involvement of hypoxia-inducible transcription factors in polycystic kidney disease,” American Journal of Pathology, vol. 170, no. 3, pp. 830–842, 2007.